Article Details

$-0.09 EPS Expected for CASI Pharmaceuticals, Inc. (CASI)

Retrieved on: 2019-07-15 09:33:17

Tags for this article:

Click the tags to see associated articles and topics

$-0.09 EPS Expected for CASI Pharmaceuticals, Inc. (CASI). View article details on hiswai:

Excerpt

<div><b>Aqr Capital Management</b> Limited Liability Company reported 0% in CASI Pharmaceuticals, Inc. (NASDAQ:CASI). Geode Mngmt Ltd accumulated ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up